Literature DB >> 193007

Hypoglycemia of infancy and nesidioblastosis. Studies with somatostatin.

H J Hirsch, S Loo, N Evans, J F Crigler, R M Filler, K H Gabbay.   

Abstract

We treated a two-month-old infant with servere intractable hypoglycemia and nesidioblastosis with continuous glucose infusions (0.75 g per kilogram per hour) via a central venous catheter. Preprandial glucose levels on this regimen were 37+/-2 mg per deciliter (+/-S.E.M.). Basal serum insulin levels were within normal fasting levels for this age group but inappropriately elevated for the blood glucose levels. The beta cells were exquisitely sensitive to infusions of synthetic cyclic somatostatin, with a dose-dependent rise in blood glucose and concomitant suppression of serum insulin levels. There was only minimal suppression of plasma glucagon levels. Single subcutaneous injections of 50 microng of protamine zinc somatostatin raised preprandial blood glucose levels to 83+/-3 mg per deciliter for four to five days although preprandial hormone levels were unchanged. These findings indicate that hypoglycemia of infancy is a hyperinsulin state with abnormal basal regulation of insulin secretion.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 193007     DOI: 10.1056/NEJM197706092962305

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  24 in total

1.  Tolerance to somatostatin analogue in a preterm infant with islet cell dysregulation syndrome.

Authors:  J M Hawdon; M P Ward Platt; W H Lamb; A Aynsley-Green
Journal:  Arch Dis Child       Date:  1991-03       Impact factor: 3.791

2.  Therapy for persistent hyperinsulinemic hypoglycemia of infancy. Understanding the responsiveness of beta cells to diazoxide and somatostatin.

Authors:  C Kane; K J Lindley; P R Johnson; R F James; P J Milla; A Aynsley-Green; M J Dunne
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

Review 3.  Adult nesidioblastosis: a case report and review of the literature.

Authors:  R D Rinker; K Friday; F Aydin; B M Jaffe; L Lambiase
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

Review 4.  Changing concepts of islet cell dysplasia in neonatal and infantile hyperinsulinism.

Authors:  C G Thomas; R E Cuenca; R G Azizkhan; L E Underwood; C N Carney
Journal:  World J Surg       Date:  1988-10       Impact factor: 3.352

5.  Hypoglycemic syndrome in infancy and childhood. A surgeon's perspective.

Authors:  A R Moossa; L Baker; M Lavelle-Jones
Journal:  West J Med       Date:  1987-05

Review 6.  Recent advances in pancreatic hormone research.

Authors:  R G Long
Journal:  Postgrad Med J       Date:  1983-05       Impact factor: 2.401

7.  Effects of somatostatin in a case of severe hypoglycemia due to nesidioblastosis.

Authors:  E Roti; C Ghinelli; P Bandini; C Del Rossi; R Emanuele; G Robuschi; A Gnudi
Journal:  J Endocrinol Invest       Date:  1981 Apr-Jun       Impact factor: 4.256

8.  Case reports; Cimetidine in the management of synchronous crises of MEA I.

Authors:  S R Friesen; A S Hermreck; C E Brackett; R N Schimke
Journal:  World J Surg       Date:  1980-01       Impact factor: 3.352

9.  Experience with 95% pancreatectomy and splenic salvage for neonatal nesidioblastosis.

Authors:  L W Martin; F C Ryckman; C A Sheldon
Journal:  Ann Surg       Date:  1984-09       Impact factor: 12.969

10.  The surgeon's approach to hypoglycemia in infants and children.

Authors:  J R Campbell
Journal:  West J Med       Date:  1987-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.